ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma

Cell Death & Disease, Published online: 07 October 2019; doi:10.1038/s41419-019-1986-2ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma

Source: Cell death and disease - October 6, 2019 Category: Internal Medicine Authors: Xiaonan Xi Ning Liu Qianqian Wang Yahui Chu Zheng Yin Yahui Ding Yaxin Lu Source Type: research